Regulation
Cannabis Regulations & Compliance in Europe
We are a strategic consultancy, not a law firm. What we provide is regulatory strategy: a commercial reading of what a framework permits, what it forbids and where the workable ground sits.
Two layers: EU and national
Some rules are set at EU level — agricultural rules for hemp, food safety and novel food authorisation, cosmetics and medicinal product law. Others, including narcotics control and most enforcement, are national.
The practical consequence is that a product may be lawfully produced in one member state and still be unsellable in another, depending on the product and jurisdiction.
Classification decides everything downstream
Before market sizing, before branding, before distribution: what is this product, legally, in the country you are targeting? Food, novel food, food supplement, cosmetic, medicinal product, controlled substance or agricultural commodity — each answer implies a different route, cost and timeline.
- Cannabinoid profile and concentration
- Format and route of administration
- Intended use and marketing claims
- Source material and extraction method
- Destination country and its enforcement practice
Novel food and cannabinoid extracts
Cannabinoid extracts and isolates intended for ingestion may be subject to novel food authorisation requirements in the EU, and national authorities apply this differently in practice. The position depends on the specific product and requires country-specific assessment.
Companies planning ingestible cannabinoid products in Europe should understand the authorisation pathway, its cost and its timeline before building the commercial plan around it.
THC thresholds and hemp
EU rules set conditions for industrial hemp cultivation, including a THC limit for approved varieties. National rules on finished products, residual THC in consumer goods and permitted formats differ, and a threshold that applies to cultivation is not automatically the threshold that applies to a finished product.
Medical and adult-use frameworks
Medical access is nationally defined and generally routed through the pharmaceutical system. Adult-use frameworks, where they exist, are national and currently tend to be non-commercial or pilot-based rather than open retail markets.
What compliance work actually involves
In practice: product classification, documentation and specification review, label and claims review against national expectations, channel-specific requirements, and a plan for what happens if a rule changes.
Related
Looking for regulatory and market-entry guidance?
Send us the product specification and the target market. We will tell you what framework it lands in and what that means commercially.
